Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
AAPS Pharmscitech
|
May 17, 2014
Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks
Hanne Kinnunen, Gerald Hebbink, Harry Peters, et al.
International Journal of Pharmaceutics
|
January 27, 2010
Characterisation and functionality of inhalation anhydrous lactose
Chonladda Pitchayajittipong, Robert Price, Jagdeep Shur, et al.
International Journal of Pharmaceutics
|
March 28, 2012
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation
Harshal A Kubavat, Jagdeep Shur, Graham Ruecroft, et al.
The Journal of Pharmacy and Pharmacology
|
August 14, 2012
Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations
Jagdeep Shur, Harshal A Kubavat, Graham Ruecroft, et al.
Drug Development and Industrial Pharmacy
|
June 24, 2008
The spray drying of unfractionated heparin: optimization of the operating parameters
Jagdeep Shur, Thomas G Nevell, Janis K Shute, et al.
AAPS Pharmscitech
|
November 16, 2014
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate
Roberto Depasquale, Sau L Lee, Bhawana Saluja, et al.
Pharmaceutical Research
|
December 14, 2011
Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations
Harshal A Kubavat, Jagdeep Shur, Graham Ruecroft, et al.
The AAPS Journal
|
June 23, 2012
Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers
Jagdeep Shur, Sau Lee, Wallace Adams, et al.
Pharmaceutical Research
|
February 2, 2008
The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations
Jagdeep Shur, Haggis Harris, Matthew D Jones, et al.
Pulmonary Pharmacology & Therapeutics
|
October 24, 2006
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics
Victoria J Broughton-Head, James R Smith, Jagdeep Shur, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
AAPS Pharmscitech
|
May 17, 2014
Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks
Hanne Kinnunen, Gerald Hebbink, Harry Peters, et al.
International Journal of Pharmaceutics
|
January 27, 2010
Characterisation and functionality of inhalation anhydrous lactose
Chonladda Pitchayajittipong, Robert Price, Jagdeep Shur, et al.
International Journal of Pharmaceutics
|
March 28, 2012
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation
Harshal A Kubavat, Jagdeep Shur, Graham Ruecroft, et al.
The Journal of Pharmacy and Pharmacology
|
August 14, 2012
Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations
Jagdeep Shur, Harshal A Kubavat, Graham Ruecroft, et al.
Drug Development and Industrial Pharmacy
|
June 24, 2008
The spray drying of unfractionated heparin: optimization of the operating parameters
Jagdeep Shur, Thomas G Nevell, Janis K Shute, et al.
AAPS Pharmscitech
|
November 16, 2014
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate
Roberto Depasquale, Sau L Lee, Bhawana Saluja, et al.
Pharmaceutical Research
|
December 14, 2011
Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations
Harshal A Kubavat, Jagdeep Shur, Graham Ruecroft, et al.
The AAPS Journal
|
June 23, 2012
Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers
Jagdeep Shur, Sau Lee, Wallace Adams, et al.
Pharmaceutical Research
|
February 2, 2008
The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations
Jagdeep Shur, Haggis Harris, Matthew D Jones, et al.
Pulmonary Pharmacology & Therapeutics
|
October 24, 2006
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics
Victoria J Broughton-Head, James R Smith, Jagdeep Shur, et al.
Page
of 4